Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Feb;8(1):69-71.
doi: 10.21037/hbsn.2018.11.07.

When lifestyles sign

Maria Guarino  1   2 , Cedric Bovet  3 , Jean-François Dufour  1   4
Affiliations
Editorial

When lifestyles sign

Maria Guarino et al. Hepatobiliary Surg Nutr. 2019 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: JF Dufour has the following conflicts of interest—advisory committees: Abbvie, Bayer, BMS, Falk, Genfit, Genkyotex, Gilead Science, Intercept, Lilly, Novartis; speaking and teaching: Abbvie, Bayer, BMS, Genfit, Gilead Science, Novartis. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Schematic diagram of NAFLD progression and the usefulness of a population screening based on the proposed serum metabolic signature after its validation, for the identification of NAFLD non-cirrhotic patients at increased risk of HCC development. This subset of patients could take advantage of the enrollment in HCC surveillance programs. NAFLD, nonalcoholic fatty liver disease; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

Comment on

References

    1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed
    1. Saran U, Humar B, Kolly P, et al. Hepatocellular carcinoma and lifestyles. J Hepatol 2016;64:203-14. 10.1016/j.jhep.2015.08.028 - DOI - PubMed
    1. Saran U, Guarino M, Rodríguez S, et al. Anti-tumoral effects of exercise on hepatocellular carcinoma growth. Hepatol Commun 2018;2:607-20. 10.1002/hep4.1159 - DOI - PMC - PubMed
    1. Piguet AC, Saran U, Simillion C, et al. Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. J Hepatol 2015;62:1296-303. 10.1016/j.jhep.2015.01.017 - DOI - PubMed
    1. Piscaglia F, Svegliati-Baroni G, Barchetti A, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. Hepatology 2016;63:827-38. 10.1002/hep.28368 - DOI - PubMed